Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New energy therapy could ease tennis elbow without drugs

NCT ID NCT07634224

Symptom relief Sponsor: Gaziantep City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special energy therapy called TECAR, combined with exercise, can reduce pain and improve function in people with tennis elbow (lateral epicondylitis). Sixty-two adults with elbow pain for at least 6 weeks will receive either real or sham TECAR therapy plus a home exercise program. Researchers will measure pain and function before, right after, and at 1 and 2 months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TECAR therapy (capacitive and resistive energy transfer) plus exercise
What this could lead to
If it works, this could provide a non-invasive, drug-free option to reduce pain and improve function in people with tennis elbow.
What could go wrong
This is a small, early-stage trial with only 62 participants. The sham control may show no added benefit over exercise alone, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 62 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with lateral epicondylitis who have experienced elbow pain for at least 6 weeks and have at least two positive provocative tests (Cozen's, Mill's, or Maudsley's test). * Age between 18 and 65 years. * Unilateral pain and tenderness over the lateral epicondyle lasting longer than 6 weeks. * Clinically diagnosed lateral epicondylitis. * No cognitive impairment. * Willingness to participate and provide informed consent. Exclusion Criteria: * History of interventional injection to the affected elbow within the previous 3 months. * Receipt of physical therapy for the affected elbow within the previous 3 months. * Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) within the previous 2 weeks. * History of fracture or surgery involving the affected elbow. * Presence of a chronic inflammatory disease. * History of malignancy. * Active infection. * Pregnancy. * Presence of a cardiac pacemaker or other electronic implant. * Coagulation disorders. * Cervical radiculopathy, entrapment neuropathy, or peripheral nerve injury. * Body mass index (BMI) ≥ 35 kg/m².

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Capacitive and resistive electric transfer therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epicondylitis Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Capacitive and resistive electric transfer therapy Exercise Lateral epicondylitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gaziantep City Hospital

    RECRUITING

    Gaziantep, Gaziantep, 06170, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.